Facebook Linkedin Twitter
Inside Precision Medicine Bladder Cancer Biomarkers Promise Improved Survival

Phase III clinical trials (Clinical trial)

Bladder Cancer
News & Features

Bladder Cancer Biomarkers Promise Improved Survival

0
Degeneration of a neuron, conceptual illustration
News & Features

MeiraGTx’s Gene Therapy for Parkinson’s Scores in Midphase Trial

0
Female nurse holding blood collection tubes for liquid biopsy
Molecular Dx

Blood Test Predicts Outcomes in Newly Diagnosed Metastatic Prostate Cancer

Laura Cowen
0
Black male cancer patient reviews results with young, white female doctor. Black patients are more likely to have the Duffy null blood type which may unnecessarily exclude them from cancer clinical trials
News & Features

Cancer Trials Exclude Individuals of African and Middle Eastern Ancestry Due to Duffy Blood Group

0
Menopausal older white woman Having a Hot Flash At Home Cooling Herself by fanning herself with paper. Such hot flashes may soon be treated with elinzanetant
News & Features

Positive Phase III Data Suggest Bayer’s Menopause Drug May Soon Be on Market

0
Asked & Answered column photo
News & Features

Predicting the Risk of Relapse in Early-Stage Melanoma

Damian Doherty
0
Brain Tumor
News & Features

New Glioma Drug Approved for First Time in Decades

0
Red Blood Cells 3D Image Concept
News & Features

Pfizer Gene Therapy for Hemophilia A Nets Positive Results, but Leaves Questions

0
Man with Duchenne muscular dystrophy sitting in a motorized wheelchair using power controller with degenerated hands
News & Features

Sarepta Wins Key Label Expansion for DMD Gene Therapy, in Wake of Pfizer Failure 

0
Tuberculosis (TB) bacteria, illustration
Coronavirus

100-Year-Old TB Vaccine Protects Type 1 Diabetics from COVID-19, Other Infectious Diseases

0
123...5Page 1 of 5

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine